<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04711889</url>
  </required_header>
  <id_info>
    <org_study_id>5A-Plan II</org_study_id>
    <nct_id>NCT04711889</nct_id>
  </id_info>
  <brief_title>Additive Anti-inflammatory Action for Aortopathy &amp; Arteriopathy (Ulinastatin) II</brief_title>
  <official_title>Effects of Ulinastatin on Inflammatory Response for Acute Aortic Syndrome Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nanjing Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Beijing Anzhen Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Nanjing Medical University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Acute Aortic Syndrome (AAS) is a common feature of acute aortic wall events, including aortic&#xD;
      dissection, intramural hematoma, aortic ulceration and aortic trauma, and occurs in up to 35&#xD;
      cases per 100,000 cases per year between the ages of 65 and 75 years. Ulinastatin has&#xD;
      antiinflammatory activity and suppresses the infiltration of neutrophils and the release of&#xD;
      elastase and chemical mediators from neutrophils. Recent studies have shown that ulinastatin&#xD;
      may be cytoprotective against ischemia-reperfusion injury in the liver, kidney, heart, and&#xD;
      lung. The authors aim to examine the association between decreased release of inflammatory&#xD;
      response to urinary trypsin inhibitor treatment and decreased myocardial and lung injury&#xD;
      after acute aortic syndrome surgery.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Oxygenation index</measure>
    <time_frame>3 days after surgery</time_frame>
    <description>Oxygenation index is calculated as PaO2/FiO2.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>30 days after surgery</time_frame>
    <description>Death from any cause</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Acute Aortic Syndrome</condition>
  <condition>Aortic Dissection</condition>
  <arm_group>
    <arm_group_label>Ulinastatin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ulinastatin 10 0000 Units is taken intravenously three times a day.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Same saline dose as ulinastatin is taken intravenously three times a day.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ulinastatin</intervention_name>
    <description>Ulinastatin is taken three times a day.</description>
    <arm_group_label>Ulinastatin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Saline</intervention_name>
    <description>Saline is taken three times a day.</description>
    <arm_group_label>Saline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  The patients are conformed to 2010 ACC/AHA guidelines for the diagnosis and treatment&#xD;
             of thoracic aortic disease (TAD) within two weeks of onset;&#xD;
&#xD;
          -  Patients with acute aortic syndrome confirmed clinically and radiologically and&#xD;
             planning to undergo emergency aortic arch replacement surgery were enrolled.&#xD;
&#xD;
          -  The patients' age between 15 ~85 years old.&#xD;
&#xD;
          -  Agree to participate in the study and sign the informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients allergic to Ulinastatin;&#xD;
&#xD;
          -  Patients with active or acute liver disease;&#xD;
&#xD;
          -  Patients with chronic kidney disease;&#xD;
&#xD;
          -  Lactating women and pregnant women;&#xD;
&#xD;
          -  Patients with mental diseases, drug and alcohol dependence;&#xD;
&#xD;
          -  Refuse to participate in this study and refuse to sign the informed consent.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Hong Liu, MD</last_name>
    <phone>02568303101</phone>
    <email>dr.hongliu@foxmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sheng Zhao, MD</last_name>
    <phone>02568303105</phone>
    <email>zhaosheng0824@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>The first affiliated hospital of nanjing medical university</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210029</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Enrolling by invitation</status>
  </location>
  <location>
    <facility>
      <name>Beijing Anzhen Hospital</name>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Si-chong Qian</last_name>
      <phone>13120130755</phone>
      <email>drqsc1990a@163.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>January 13, 2021</study_first_submitted>
  <study_first_submitted_qc>January 13, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 15, 2021</study_first_posted>
  <last_update_submitted>August 9, 2021</last_update_submitted>
  <last_update_submitted_qc>August 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Nanjing Medical University</investigator_affiliation>
    <investigator_full_name>Hong Liu</investigator_full_name>
    <investigator_title>Investigator of Nanjing Medical University</investigator_title>
  </responsible_party>
  <keyword>Acute Aortic Syndrome</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aneurysm, Dissecting</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinastatin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

